Search Within

Andrew Joseph Plodkowski

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (34)
  2. Meeting Abstract (15)
Groups
  1. Body Imaging Service (49)
  2. Department of Pathology and Laboratory Medicine (49)
  3. Radiology, Department of (49)
  4. Department of Medicine (45)
  5. Solid Tumor Oncology Division (43)
  6. Thoracic Oncology (42)

More Groups

People
  1. Matthew Hellmann (24)
  2. Charles Rudin (23)
  3. Mark Kris (23)
  4. Marc Ladanyi (22)
  5. Natasha Rekhtman (21)
  6. Gregory Riely (20)

More People

Years
  1. 2024 (2)
  2. 2023 (7)
  3. 2022 (4)
  4. 2021 (5)
  5. 2020 (7)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (7)
  3. Clinical Cancer Research (6)
  4. Annals of Oncology (4)
  5. Cancer Cell (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Inc. (11)
  3. American Association for Cancer Research (8)
  4. Oxford University Press (5)
  5. Cell Press (2)
  6. Elsevier Ireland Ltd. (2)

More Publishers

Results (49)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute lung injury pattern is a frequent histologic finding in lung tissue following immune checkpoint inhibitor therapy
    Meeting Abstract

    Golden, A.; Imran, S.; Feinstein, M.; Hellmann, M.; Plodkowski, A.; Rekhtman, N.; Rizvi, H.; Travis, W.; Stover, D.; Sauter, J.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Schoenfeld, A. J.; Plodkowski, A. J.; Odintsov, I.; Lu, D.; Lockwood, W. W.; Arcila, M. E.; Rudin, C. M.; Drilon, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: A retrospective international multicentre study
    Journal Article

    Lai, W. V.; Lebas, L.; Barnes, T. A.; Milia, J.; Ni, A.; Gautschi, O.; Peters, S.; Ferrara, R.; Plodkowski, A. J.; Kavanagh, J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Type A thymoma presenting with bone metastasis
    Journal Article

    Montecalvo, J.; Chang, J.; Rekhtman, N.; Antonescu, C. R.; Bains, M. S.; Fabbri, N.; Plodkowski, A. J.; Riely, G. J.; Travis, W. D.; Sauter, J. L.
    Histopathology (2018)

    Fulltext@MSK | Save
  • STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma
    Journal Article

    Skoulidis, F.; Goldberg, M. E.; Greenawalt, D. M.; Hellmann, M. D.; Awad, M. M.; Gainor, J. F.; Schrock, A. B.; Hartmaier, R. J.; Trabucco, S. E.; Gay, L.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save